Aberrant expression of nuclear matrix proteins during HMBA-induced differentiation of gastric cancer cells

World Journal of Gastroenterology

Volumn 16, Issue 17, 2010, Pages 2176-2182

  Jing, Guang Jun ^a   Xu, Dong Hui ^b   Shi, Song Lin ^a   Li, Qi Fu ^a   Wang, San Ying ^a   Wu, Fu Yun ^a   Kong, Hai Yan ^a  

^a XIAMEN UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

Author keywords

Differentiation; Hexamethylene bisacetamide; Human gastric tumor cell; Nuclear matrix; Proliferation

Indexed keywords

CALCIUM BINDING PROTEIN; CALNEXIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A2; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN B1; HEXAMETHYLENEBISACETAMIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; MEMBRANE ASSOCIATED GUANYLATE CYCLASE KINASE; NUCLEAR MATRIX PROTEIN; NUCLEOPHOSMIN; PEROXIREDOXIN 2; PROHIBITIN; SIGNAL PEPTIDE; UNCLASSIFIED DRUG; VIMENTIN; ZINC FINGER PROTEIN;

ARTICLE; CANCER CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEOMICS; STOMACH CANCER; TWO DIMENSIONAL ELECTROPHORESIS; UPREGULATION;

EID: 77952478507     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i17.2176     Document Type: Article

References (25)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999; 80: 827-841
2. Brünagel G, Schoen RE, Bauer AJ, Vietmeier BN, Getzenberg RH. Nuclear matrix protein alterations associated with colon cancer metastasis to the liver. Clin Cancer Res 2002; 8: 3039-3045
3. Marchisio M, Santavenere E, Paludi M, Gaspari AR, Lanuti P, Bascelli A, Ercolino E, Di Baldassarre A, Miscia S. Erythroid cell differentiation is characterized by nuclear matrix localization and phosphorylation of protein kinases C (PKC) alpha, delta, and zeta. J Cell Physiol 2005; 205: 32-36
4. Coffey DS. Nuclear matrix proteins as proteomic markers of preneoplastic and cancer lesions: commentary re: G. Brunagel et al., nuclear matrix protein alterations associated with colon cancer metastasis to the liver. Clin. Cancer Res., 8: 3039-3045, 2002.
5. Coffey DS. Nuclear matrix proteins as proteomic markers of preneoplastic and cancer lesions: commentary re: G. Brunagel et al., nuclear matrix protein alterations associated with colon cancer metastasis to the liver. Clin Cancer Res 2002; 8: 3031-3033
6. Shi SL, Wang YY, Liang Y, Li QF. Effects of tachyplesin and n-sodium butyrate on proliferation and gene expression of human gastric adenocarcinoma cell line BGC-823. World J Gastroenterol 2006; 12: 1694-1698
7. Zhao CH, Li QF, Zhao Y, Niu JW, Li ZX, Chen JA. Changes of nuclear matrix proteins following the differentiation of human osteosarcoma MG-63 cells. Genomics Proteomics Bioinformatics 2006; 4: 10-17
8. Contreras X, Barboric M, Lenasi T, Peterlin BM. HMBA releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K/Akt and activates HIV transcription. PLoS Pathog 2007; 3: 1459-1469
9. Zhao CH, Li QF. Altered profiles of nuclear matrix proteins during the differentiation of human gastric mucous adenocarcinoma MGc80-3 cells. World J Gastroenterol 2005; 11: 4628-4633
10. Zhang G, Wang G, Wang S, Li Q, Ouyang G, Peng X. Applying proteomic methodologies to analyze the effect of hexamethylene bisacetamide (HMBA) on proliferation and differentiation of human gastric carcinoma BGC-823 cells. Int J Biochem Cell Biol 2004; 36: 1613-1623
11. Michishita E, Kurahashi T, Suzuki T, Fukuda M, Fujii M, Hirano H, Ayusawa D. Changes in nuclear matrix proteins during the senescence-like phenomenon induced by 5-chlorodeoxyuridine in HeLa cells. Exp Gerontol 2002; 37: 885-890
12. Sheffield JB. Image J, A useful tool for biological image processing and analysis. Microsc Microanal 2007; 13 Suppl 2: 200-201
13. Liang Y, Li QF, Zhang XY, Shi SL, Jing GJ. Differential expression of nuclear matrix proteins during the differentiation of human neuroblastoma SK-N-SH cells induced by retinoic acid. J Cell Biochem 2009; 106: 849-857
14. Li QF, Shi SL, Liu QR, Tang J, Song J, Liang Y. Anticancer effects of ginsenoside Rg1, cinnamic acid, and tanshinone IIA in osteosarcoma MG-63 cells: nuclear matrix downregulation and cytoplasmic trafficking of nucleophosmin. Int J Biochem Cell Biol 2008; 40: 1918-1929
15. Xu DH, Tang J, Li QF, Shi SL, Chen XF, Liang Y. Positional and expressive alteration of prohibitin during the induced differentiation of human hepatocarcinoma SMMC-7721 cells. World J Gastroenterol 2008; 14: 5008-5014
16. Tang J, Niu JW, Xu DH, Li ZX, Li QF, Chen JA. Alteration of nuclear matrix-intermediate filament system and differential expression of nuclear matrix proteins during human hepatocarcinoma cell differentiation. World J Gastroenterol 2007; 13: 2791-2797
17. Krüger T, Zentgraf H, Scheer U. Intranucleolar sites of ribosome biogenesis defined by the localization of early binding ribosomal proteins. J Cell Biol 2007; 177: 573-578
18. Getzenberg RH, Konety BR, Oeler TA, Quigley MM, Hakam A, Becich MJ, Bahnson RR. Bladder cancer-associated nuclear matrix proteins. Cancer Res 1996; 56: 1690-1694
19. Brünagel G, Vietmeier BN, Bauer AJ, Schoen RE, Getzenberg RH. Identification of nuclear matrix protein alterations associated with human colon cancer. Cancer Res 2002; 62: 2437-2442
20. Konety BR, Nguyen TS, Dhir R, Day RS, Becich MJ, Stadler WM, Getzenberg RH. Detection of bladder cancer using a novel nuclear matrix protein, BLCA-4. Clin Cancer Res 2000; 6: 2618-2625
21. Gamble SC, Chotai D, Odontiadis M, Dart DA, Brooke GN, Powell SM, Reebye V, Varela-Carver A, Kawano Y, Waxman J, Bevan CL. Prohibitin, a protein downregulated by androgens, represses androgen receptor activity. Oncogene 2007; 26: 1757-1768
22. Ummanni R, Junker H, Zimmermann U, Venz S, Teller S, Giebel J, Scharf C, Woenckhaus C, Dombrowski F, Walther R. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer. Cancer Lett 2008; 266: 171-185
23. Qi W, Shakalya K, Stejskal A, Goldman A, Beeck S, Cooke L, Mahadevan D. NSC348884, a nucleophosmin inhibitor disrupts oligomer formation and induces apoptosis in human cancer cells. Oncogene 2008; 27: 4210-4220
24. Maggi LB Jr, Kuchenruether M, Dadey DY, Schwope RM, Grisendi S, Townsend RR, Pandolfi PP, Weber JD. Nucleophosmin serves as a rate-limiting nuclear export chaperone for the Mammalian ribosome. Mol Cell Biol 2008; 28: 7050-7065
25. Zech VF, Dlaska M, Tzankov A, Hilbe W. Prognostic and diagnostic relevance of hnRNP A2/B1, hnRNP B1 and S100 A2 in non-small cell lung cancer. Cancer Detect Prev 2006; 30: 395-402